Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Burke

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
JMIR Medical Education|December 21, 2022
Defining a Role for Webinars in Surgical Training Beyond the COVID-19 Pandemic in the United Kingdom: Trainee Consensus Qualitative StudyEmma Barlow, Wajiha Zahra, Jane Hornsby, et al.
Psychopharmacology Bulletin|August 26, 2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood DisorderChristoph U Correll, Richard C Josiassen, Grace S Liang, et al.
Psychopharmacology Bulletin|August 26, 2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective DisorderJohn M Kane, Christoph U Correll, Grace S Liang, et al.
Psychopharmacology Bulletin|August 26, 2017
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood DisorderRichard C Josiassen, John M Kane, Grace S Liang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|September 25, 2014
Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral densityBruce Carr, W Paul Dmowski, Chris O'Brien, et al.
Journal of Affective Disorders|December 25, 2018
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorderRoger S McIntyre, Joseph R Calabrese, Andrew A Nierenberg, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 6, 2023
A new horizon for surgical research in a digital world: A national operation notes systemGrant S Nolan, Alex J Parker, Ailbhe L Kiely, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 5, 2026
Modulation of the gut microbiota as a novel strategy to prevent anastomotic leak after colorectal surgery: Systematic scoping reviewJack A Helliwell, Peter Sciberras, Alexios Dosis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 9, 2015
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled studyChristopher F O'Brien, Roland Jimenez, Robert A Hauser, et al.
CNS Spectrums|May 19, 2020
A long-term, open-label study of valbenazine for tardive dyskinesiaJean-Pierre Lindenmayer, Cherian Verghese, Stephen R Marder, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
JMIR Medical Education|December 21, 2022
Defining a Role for Webinars in Surgical Training Beyond the COVID-19 Pandemic in the United Kingdom: Trainee Consensus Qualitative StudyEmma Barlow, Wajiha Zahra, Jane Hornsby, et al.
Psychopharmacology Bulletin|August 26, 2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood DisorderChristoph U Correll, Richard C Josiassen, Grace S Liang, et al.
Psychopharmacology Bulletin|August 26, 2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective DisorderJohn M Kane, Christoph U Correll, Grace S Liang, et al.
Psychopharmacology Bulletin|August 26, 2017
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood DisorderRichard C Josiassen, John M Kane, Grace S Liang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|September 25, 2014
Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral densityBruce Carr, W Paul Dmowski, Chris O'Brien, et al.
Journal of Affective Disorders|December 25, 2018
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorderRoger S McIntyre, Joseph R Calabrese, Andrew A Nierenberg, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 6, 2023
A new horizon for surgical research in a digital world: A national operation notes systemGrant S Nolan, Alex J Parker, Ailbhe L Kiely, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 5, 2026
Modulation of the gut microbiota as a novel strategy to prevent anastomotic leak after colorectal surgery: Systematic scoping reviewJack A Helliwell, Peter Sciberras, Alexios Dosis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 9, 2015
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled studyChristopher F O'Brien, Roland Jimenez, Robert A Hauser, et al.
CNS Spectrums|May 19, 2020
A long-term, open-label study of valbenazine for tardive dyskinesiaJean-Pierre Lindenmayer, Cherian Verghese, Stephen R Marder, et al.
Pageof 3